TNBIOTCGrain Mill ProductsFiscal year ends December 31
Tanke Biosciences Corp
Financials through Q3 FY2013, quarter ended Sep 30, 2013Last filing: 10-Q on Nov 14, 2013
$0.03+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $399.72K
- P/E (TTM)
- –
- Dividend yield
- –
Tanke Biosciences Corp revenue by segment
By business segment
| Revenue | Q3 13 | Q2 13 | Q1 13 | Q4 12 | Q3 12 | Q2 12 | Q1 12 | Q4 11 | Q3 11 | Q2 11 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organic Trace Mineral Additives [Member] | $4.73M | $4.31M | $3.88M | $5.82M | $8.87M | $6.51M | $3.39M | $4.69M | $5.15M | $3.94M | 78.3% | -46.6% |
| Functional Regulation Additives [Member] | $613.13K | $498.89K | $496.49K | $576.52K | $733.79K | $844.64K | $901.90K | $1.60M | $998.37K | $948.66K | 10.1% | -16.4% |
| Other [Member] | $388.51K | $443.59K | $201.15K | $180.11K | $212.96K | $20.22K | $210.05K | $312.73K | $6.36K | $19.04K | 6.4% | +82.4% |
| Herbal Medicinal Additives [Member] | $309.04K | $328.29K | $79.50K | $102.34K | $94.27K | $54.25K | $42.59K | $56.37K | $93.33K | $83.02K | 5.1% | +227.8% |
By product or service
By region
From the segment and revenue-disaggregation notes of Tanke Biosciences's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.